메뉴 건너뛰기




Volumn 19, Issue 21, 2012, Pages 3605-3621

Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: A medicinal chemistry perspective

Author keywords

Chemical modification; CYP inhibition; Cytochrome P450; Drug discovery; Heterocylic compounds; Medicinal chemistry; Physicochemical properties; Structure activity relationship

Indexed keywords

ACYL COENZYME A DESATURASE INHIBITOR; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; BENZIMIDAZOL PYRIDINONE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR3 ANTAGONIST; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; ENZYME INHIBITOR; IGFR1R INHIBITOR; IMIDAZOLE; KAPPA OPIATE RECEPTOR AGONIST; KETOCONAZOLE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MORPHOLINE DERIVATIVE; OXIDOREDUCTASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PYRAZOLOQUINOLINE DERIVATIVE; PYRIDINE DERIVATIVE; QUINOLINE DERIVATIVE; RHO KINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; XANTHENE OXIDASE INHIBITOR;

EID: 84863735141     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801323180     Document Type: Review
Times cited : (51)

References (43)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.